GlassScriptPhysician profile
Jordon Blackmon
NPI 1407640725
$793.15
in general payments reported to CMS, 2019-2025
15 companies · $793 in 2025
The $793 reported for 2025 was more than what 87% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.15 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $124.48 | 2025 | Xtandi |
| Teleflex LLC | $99.53 | 2025 | Urolift, Barrigel |
| Bayer Healthcare Pharmaceuticals INC. | $94.45 | 2025 | |
| Endo USA, INC. | $80.54 | 2025 | Xiaflex |
| Urogen Pharma, INC. | $74.20 | 2025 | |
| Verity Pharmaceuticals INC. | $52.03 | 2025 | Tlando |
| Antares Pharma, INC. | $41.12 | 2025 | Xyosted |
| C. R. Bard, INC. & Subsidiaries | $37.28 | 2025 | Magic3 Go Intermittent Urinary Catheter, Bard Urinary Drainage Bag |
| Laborie Medical Technologies Corp. | $37.16 | 2025 | |
| Tempus Ai, INC | $29.60 | 2025 | Xt Cdx |
| Sumitomo Pharma America, INC. | $29.27 | 2025 | Gemtesa |
| Tolmar, INC. | $26.80 | 2025 | Eligard |
| Dendreon Pharmaceuticals LLC | $26.30 | 2025 | Provenge |
| Merck Sharp & Dohme LLC | $23.08 | 2025 | Welireg, Keytruda |
| Progenics Pharmaceuticals, INC. | $17.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordon Blackmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.